For decades, magnesium sat in the supplement aisle as a mineral for muscle cramps, sleep, and general nutrition. Around 2010, that changed. A branded form called magnesium L-threonate launched on the back of a 2010 MIT rodent paper, and a new category was born — magnesium for the brain. Fifteen years later, that category has expanded to include other brand-targeted forms, premium price points, and confident claims about cognition, memory, and synaptic density. In this investigation, we review the science underneath those claims.
IN THIS INVESTIGATION
What two papers from 1984 actually said about magnesium and the brain
Why magnesium concentrates differently in brain fluid than in blood, and what that implies for supplementation
The 2010 MIT paper that launched the brand-targeted magnesium category, and the question it didn't answer
What you find when you trace the authorship of the rodent studies that "independently confirmed" the original
The magnesium acetyl taurate line and what a 2026 head-to-head comparison reveals about form-specific brain delivery
Every human trial on magnesium L-threonate, who funded each one, and the structural feature they all share
The 2024 paper that directly measured magnesium inside living human brains for the first time in twenty-five years
What the ordinary forms — citrate, chloride, oxide — have actually demonstrated in independent human trials
Why a failed 2007 traumatic brain injury trial matters for everything that followed
The single piece of evidence the brand-targeted magnesium story has never produced
What to do if you take magnesium for cognitive reasons
Subscribe for more investigations.
